50 participants
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2025-05-26
- Completion:
- 2030-12-30
Conditions
- Malignant Neoplasm
Interventions
- BIOLOGICAL
No Results Yet